drugset / Trial / NCT03845023
Trial of AD036 in Obstructive Sleep Apnea
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double blind, placebo-controlled, repeat-dose, parallel arm, outpatient and inpatient phase 2 clinical study to examine the efficacy and safety of three dose levels of AD036 versus placebo in patients with obstructive sleep apnea.
Timeline
- Start
- 2019-03-07
- Primary completion
- 2019-10-23
- Completion
- 2019-10-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atomoxetine | Other / unclassified | — | Oral |
| Subject | Oxybutynin | Small molecule | — | Oral |